143 related articles for article (PubMed ID: 8363991)
1. Fever and neutropenia during intensive chemotherapy.
Klastersky J
Ann Oncol; 1993 Aug; 4(7):603-6. PubMed ID: 8363991
[No Abstract] [Full Text] [Related]
2. Treatment of fever and neutropenia with antibiotics versus antibiotics plus intravenous gammaglobulin in childhood leukemia.
Sumer T; Abumelha A; al-Mulhim I; al-Fadil M
Eur J Pediatr; 1989 Feb; 148(5):401-2. PubMed ID: 2493376
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial therapy--special considerations in neutropenic patients.
Rodriguez V; Bodey GP
Clin Haematol; 1976 Jun; 5(2):347-60. PubMed ID: 181192
[No Abstract] [Full Text] [Related]
4. Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure.
Pea F; Viale P; Damiani D; Pavan F; Cristini F; Fanin R; Furlanut M
Antimicrob Agents Chemother; 2005 Aug; 49(8):3550-3. PubMed ID: 16048982
[TBL] [Abstract][Full Text] [Related]
5. Empiric antimicrobial therapy in the febrile granulocytopenic patient.
Hughes WT
Infect Control Hosp Epidemiol; 1990 Mar; 11(3):151-6. PubMed ID: 2179402
[No Abstract] [Full Text] [Related]
6. Lithium and granulocytopenia during induction therapy of acute myelogenous leukemia: update of an ongoing trial.
Stein RS; Flexner JH; Graber SE
Adv Exp Med Biol; 1980; 127():187-97. PubMed ID: 6931477
[No Abstract] [Full Text] [Related]
7. [Amikacin in the treatment of febrile complications occurring during the neutropenic phase of acute hemopathies].
Fiere D; Vu Van H; Espinouse D; Reynaud J; Coiffier B; Felman P; Vialard L
Nouv Presse Med; 1979 Oct; 8(42):3469-71. PubMed ID: 295114
[No Abstract] [Full Text] [Related]
8. The febrile neutropenic patient: newer options for empirical therapy.
Rubin M; Walsh T; Butler K; Lee J; Lecciones J; Weinberger M; Roilides E; Gress J; Marshall D; Pizzo PA
Haematol Blood Transfus; 1990; 33():531-8. PubMed ID: 2157645
[No Abstract] [Full Text] [Related]
9. Neutropenia and fever.
Hughes WT
Pediatr Infect Dis; 1983; 2(3 Suppl):S14-7. PubMed ID: 6866796
[No Abstract] [Full Text] [Related]
10. Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors.
Wiley JM; Smith N; Leventhal BG; Graham ML; Strauss LC; Hurwitz CA; Modlin J; Mellits D; Baumgardner R; Corden BJ
J Clin Oncol; 1990 Feb; 8(2):280-6. PubMed ID: 2299371
[TBL] [Abstract][Full Text] [Related]
11. Application of the IDSA guidelines for the use of antimicrobial agents in neutropenic patients: impact on reducing the use of glycopeptides.
Nucci M; Landau M; Silveira F; Spector N; Pulcheri W
Infect Control Hosp Epidemiol; 2001 Oct; 22(10):651-3. PubMed ID: 11776354
[TBL] [Abstract][Full Text] [Related]
12. [Combination of a 3d-generation cephalosporin (cefotaxime or ceftazidime) and a new quinolone (pefloxacine) in the treatment of febrile episodes in neutropenic diseases (37 cases)].
Guy H; Caillot D; Solary E; Bielefeld P; Portier H; Kazmierczak A
Presse Med; 1987 Dec; 16(43):2172-5. PubMed ID: 2963306
[TBL] [Abstract][Full Text] [Related]
13. [Fever in patients with cancer].
Watanabe K
Rinsho Byori; 2009 May; Suppl 143():112-5. PubMed ID: 20845880
[No Abstract] [Full Text] [Related]
14. Comparison of cefepime versus ceftriaxone-amikacin as empirical regimens for the treatment of febrile neutropenia in acute leukemia patients.
Borbolla JR; López-Hernández MA; González-Avante M; DeDiego J; Trueba E; Alvarado ML; Jiménez RM
Chemotherapy; 2001; 47(5):381-4. PubMed ID: 11561142
[TBL] [Abstract][Full Text] [Related]
15. Pre-sepsis prophylaxis and empirical treatment of febrile patients with neutropenia in acute leukaemia.
Advani SH; Ahuja HG; Pai MR; Saikia T; Gopal R; Nair CN
J Assoc Physicians India; 1986 Aug; 34(8):559-62. PubMed ID: 3466893
[No Abstract] [Full Text] [Related]
16. Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patients.
Fainstein V; Bodey GP; Bolivar R; Elting L; McCredie KB; Keating MJ
Arch Intern Med; 1984 Sep; 144(9):1766-70. PubMed ID: 6383246
[TBL] [Abstract][Full Text] [Related]
17. Failure of lithium to reduce period of neutropenia during induction therapy of acute myeloid leukemia.
Scarffe JH; Chang J
Hematol Oncol; 1989; 7(1):69-75. PubMed ID: 2491829
[TBL] [Abstract][Full Text] [Related]
18. Systemic broad-spectrum antimicrobial prophylaxis in hematological patients after intensive antineoplastic chemotherapy.
Verlicchi F; Ricci P; Bassi A; Benfenati D; Bandini G; Rosti G; Calori E; Borghi C; Tura S
Haematologica; 1990; 75(1):91-3. PubMed ID: 2338294
[TBL] [Abstract][Full Text] [Related]
19. Management of fever in neutropenic patients with acute leukemia: current role of ceftazidime plus amikacin as empiric therapy.
Fanci R; Paci C; Martinez RL; Fabbri A; Pecile P; Leoni F; Longo G
J Chemother; 2000 Jun; 12(3):232-9. PubMed ID: 10877519
[TBL] [Abstract][Full Text] [Related]
20. Management in the febrile, neutropenic patient with cancer: therapeutic considerations.
Brown AE
J Pediatr; 1985 Jun; 106(6):1035-42. PubMed ID: 3889253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
